Benaim Ely 4
4 · NovoCure Ltd · Filed Aug 4, 2022
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Benaim Ely
Chief Medical Officer
Transactions
- Sale
Ordinary Shares
2022-08-03$74.00/sh−5,396$399,304→ 28,672 total - Sale
Ordinary Shares
2022-08-03$71.09/sh−563$40,024→ 34,068 total
Footnotes (1)
- [F1]Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim.